Registration number: 12586186

Cambridge Sensoriis Ltd

Contents

Company Information	1
Directors' Report	2
Balance Sheet	3 to 4
Notes to the Unaudited Financial Statements	5 to 10

Cambridge Sensoriis Ltd

Company Information

Directors

Dr Stephen Clark Mr Richard Higgs Mr Thomas Alexander Hearn Mr Michael Hall

Registered office

20-22 Wenlock Road London England N1 7GU

Accountants

Mrs Victoria Anne Cooper Red Shoes Accounting Services Unit 7 E-Space North 181 Wisbech Road Littleport Cambridgeshire CB6 1RA

Cambridge Sensoriis Ltd

Directors' Report for the Year Ended 31 March 2026

The directors present their report and the financial statements for the year ended 31 March 2026.

Directors of the company

The directors who held office during the year were as follows:

Dr Stephen Clark

Mr Richard Higgs

Ms Joanna Hill (appointed 24 April 2025 and ceased 5 June 2026)

Mr Thomas Alexander Hearn

Mr Michael Hall

Principal activity

The principal activity of the company is that of engineering design activities and consulting

Going concern

The financial statements have been prepared on the going concern basis which assumes that the company will continue as a going concern for the foreseeable future. The validity of this assumption depends on the directors and shareholders continuing to provide adequate financial support.

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved by the Board on 1 October 2026 and signed on its behalf by:

Dr Stephen Clark Director

Cambridge Sensoriis Ltd

(Registration number: 12586186)
Balance Sheet as at 31 March 2026

	Note	2026 £	(As restated) 2025 £
Fixed assets
Tangible assets	4	9,683	11,218
Current assets
Debtors	5	376,291	285,318
Cash at bank and in hand		146,290	160,037
		522,581	445,355
Creditors: Amounts falling due within one year	6	(96,123)	(64,939)
Net current assets		426,458	380,416
Total assets less current liabilities		436,141	391,634
Creditors: Amounts falling due after more than one year	6	(311,934)	-
Net assets		124,207	391,634
Capital and reserves
Called up share capital	7	122	122
Share premium reserve		658,931	658,931
Other reserves		173,816	153,421
Retained earnings		(708,662)	(420,840)
Shareholders' funds		124,207	391,634

For the financial year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account and Directors' Report.

Approved and authorised by the Board on 1 October 2026 and signed on its behalf by:
 

Cambridge Sensoriis Ltd

(Registration number: 12586186)
Balance Sheet as at 31 March 2026

Dr Stephen Clark Director

Cambridge Sensoriis Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026

1	General information

The company is a private company limited by share capital, incorporated in England & Wales .

The address of its registered office is:
20-22 Wenlock Road
London
N1 7GU
England

These financial statements were authorised for issue by the Board on 1 October 2026.

2	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Prior period errors

During the financial year, a material calculation error was identified relating to the spreadsheet formula used to calculate the share-based payment charge for the Enterprise Management Incentive share option schemes in prior periods. This error has been corrected retrospectively by restating the comparative figures for the prior year ended 31 March 2025. The adjustments have resulted in a reduction in the Profit and Loss Reserve, offset by a corresponding increase in the Share-Based Payment Reserve (a non-distributable equity reserve).

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Page 5

Cambridge Sensoriis Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026

Government grants

Grants are accounted under the accruals model as permited by FRS102. Grants relating to expenditure on tangible fixed assets are credited to profit or loss at the same rate as the deprecition on the assets to which the grant relates. The deferred element of grants is incuded in creditors as deferred income. Where a grant is claimed after the related revenue expenditure has been incurred, the grant is recognised as income in the same period as the expenditure, provided that there is reasonable assurance that the grant will be received and the conditions attached have been or will be met.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Furniture, fittings and equipment	25% reducing balance
Other tangible assets	25% reducing balance

Cambridge Sensoriis Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Cambridge Sensoriis Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

Share based payments

The company operates an equity-settled, share-based compensation plan, under which the entity receives services from employees as consideration for equity instruments (options) of the entity. The fair value of the employee services received is measured by reference to the estimated fair value at the grant date of equity instruments granted and is recognised as an expense over the vesting period. The total amount expensed is recognised over the vesting period, which is the period over which all of the specified vesting conditions are to be satisfied. The charge recognised in the profit and loss account for the year in respect of the Enterprise Management Incentive share option schemes was £20,395 and at 31 March 2026 the cumulative balance on the share‑based payment reserve was £173,816.

The proceeds received net of any directly attributable transaction costs are credited to share capital (nominal value) and share premium when the options are exercised.

3	Staff numbers

The average number of persons employed by the company (including directors) during the year, was 13 (2025 - 14).

Cambridge Sensoriis Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026

4	Tangible assets

	Furniture, fittings and equipment  £	Other tangible assets £	Total £
Cost or valuation
At 1 April 2025	21,083	862	21,945
Additions	1,477	-	1,477
At 31 March 2026	22,560	862	23,422
Depreciation
At 1 April 2025	10,511	216	10,727
Charge for the year	2,851	161	3,012
At 31 March 2026	13,362	377	13,739
Carrying amount
At 31 March 2026	9,198	485	9,683
At 31 March 2025	10,572	646	11,218

5

Debtors

Current	2026 £	2025 £
Trade debtors	162,190	150,336
Prepayments	22,254	5,022
Other debtors	191,847	129,960
	376,291	285,318

6

Creditors

Creditors: amounts falling due within one year

	2026 £	2025 £
Due within one year
Trade creditors	359	-
Taxation and social security	74,678	54,112
Accruals and deferred income	1,000	2,100
Other creditors	20,086	8,727
	96,123	64,939

Cambridge Sensoriis Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026

Creditors: amounts falling due after more than one year

	Note	2026 £	2025 £
Due after one year
Loans and borrowings	8	311,934	-

The loan is secured by a fixed and floating charge over the company's assets.

7	Share capital

Allotted, called up and fully paid shares

	2026		2025
	No.	£	No.	£
Ordinary Shares of £0.00 each	121,583	122	121,583	122

8	Loans and borrowings

Non-current loans and borrowings

	2026 £	2025 £
Other borrowings	311,934	-

9	Obligations under leases and hire purchase contracts

Operating leases

The total of future minimum lease payments is as follows:

	2026 £	2025 £
Not later than one year	1,650	1,650